Mar 05, 2012, 10.28 AM | Source: Reuters
Cipla said it had received government notices seeking Rs 425 crore due to over pricing of certain drugs.
The demands are contrary to the orders passed by the Supreme Court of India and are related to the same drugs under litigation, the drugmaker said in a statement.
The company has received a legal advice which says the entire amount demanded by the National Pharmaceutical Pricing Authority (NPPA) is not tenable and sustainable, Cipla said.
NPPA is a government body that fines drugmakers in India if they over price certain drugs that have been identified under the national list of essential medicines.
CNBC-TV18's Ekta Batra lists out stocks that you s
"United States Food and Drug Administration (USFDA
Cipla shares fell 6.5 percent intraday Friday afte
Ashwani Gujral of ashwanigujral.com advises sellin
"The environment for domestic pharma companies rem